Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 25, 2024

BUY
$4.82 - $6.93 $303,602 - $436,506
62,988 Added 291.62%
84,587 $439,000
Q4 2023

Feb 02, 2024

BUY
$5.63 - $8.27 $14,885 - $21,865
2,644 Added 13.95%
21,599 $146,000
Q3 2023

Nov 01, 2023

SELL
$6.71 - $11.83 $27,967 - $49,307
-4,168 Reduced 18.03%
18,955 $127,000
Q2 2023

Aug 04, 2023

BUY
$11.12 - $22.2 $257,127 - $513,330
23,123 New
23,123 $264,000
Q4 2022

Feb 02, 2023

BUY
$18.12 - $27.32 $259,442 - $391,167
14,318 Added 49.31%
43,355 $982,000
Q3 2022

Nov 04, 2022

SELL
$16.98 - $25.54 $2.75 Million - $4.13 Million
-161,804 Reduced 84.78%
29,037 $544,000
Q2 2022

Aug 03, 2022

BUY
$13.15 - $20.45 $2.29 Million - $3.56 Million
173,862 Added 1023.98%
190,841 $3.56 Million
Q1 2022

May 02, 2022

BUY
$14.54 - $21.5 $19,788 - $29,261
1,361 Added 8.71%
16,979 $306,000
Q2 2021

Aug 12, 2021

BUY
$29.97 - $37.17 $177,841 - $220,566
5,934 Added 61.28%
15,618 $481,000
Q1 2021

Apr 26, 2021

BUY
$29.24 - $42.03 $41,842 - $60,144
1,431 Added 17.34%
9,684 $326,000
Q4 2020

Feb 02, 2021

BUY
$35.35 - $50.67 $291,743 - $418,179
8,253 New
8,253 $298,000
Q3 2020

Oct 14, 2020

SELL
$35.98 - $47.66 $850,603 - $1.13 Million
-23,641 Closed
0 $0
Q2 2020

Jul 13, 2020

BUY
$45.06 - $67.74 $1.07 Million - $1.6 Million
23,641 New
23,641 $1.07 Million
Q1 2020

Apr 29, 2020

SELL
$40.01 - $73.97 $185,046 - $342,111
-4,625 Closed
0 $0
Q4 2019

Feb 05, 2020

SELL
$37.13 - $74.62 $24,245 - $48,726
-653 Reduced 12.37%
4,625 $331,000
Q3 2019

Oct 15, 2019

SELL
$39.36 - $76.8 $596,933 - $1.16 Million
-15,166 Reduced 74.18%
5,278 $207,000
Q2 2019

Jul 26, 2019

BUY
$52.76 - $82.19 $1.02 Million - $1.6 Million
19,414 Added 1884.85%
20,444 $1.6 Million
Q1 2019

Apr 18, 2019

BUY
$27.39 - $68.41 $28,211 - $70,462
1,030 New
1,030 $0
Q4 2018

Jan 16, 2019

SELL
$22.8 - $33.93 $140,881 - $209,653
-6,179 Closed
0 $0
Q3 2018

Oct 23, 2018

SELL
$29.75 - $43.08 $206,227 - $298,630
-6,932 Reduced 52.87%
6,179 $224,000
Q2 2018

Jul 30, 2018

SELL
$21.96 - $39.94 $501,171 - $911,510
-22,822 Reduced 63.51%
13,111 $495,000
Q1 2018

Apr 26, 2018

BUY
$17.1 - $26.61 $266,965 - $415,435
15,612 Added 76.83%
35,933 $844,000
Q4 2017

Jan 10, 2018

BUY
$9.47 - $19.59 $192,439 - $398,088
20,321
20,321 $398,000

Others Institutions Holding QURE

About uniQure N.V.


  • Ticker QURE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,729,100
  • Market Cap $300M
  • Description
  • uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...
More about QURE
Track This Portfolio

Track Simplex Trading, LLC Portfolio

Follow Simplex Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.